111 related articles for article (PubMed ID: 27449565)
1. Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS.
Chen TS; Chen YT; Liu CH; Sun CC; Mao FC
Gynecol Endocrinol; 2017 Jan; 33(1):48-52. PubMed ID: 27449565
[TBL] [Abstract][Full Text] [Related]
2. Effect of Chromium Supplementation on Element Distribution in a Mouse Model of Polycystic Ovary Syndrome.
Chen TS; Chen YT; Liu CH; Sun CC; Mao FC
Biol Trace Elem Res; 2015 Dec; 168(2):472-80. PubMed ID: 26041153
[TBL] [Abstract][Full Text] [Related]
3. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
4. [Expression of steroidogenic enzymes in the rat model of polycystic ovary syndrome].
Lin W; Song ZJ; Sun WM; Dong L; Jin KK; Wang WT; Wang Y
Sheng Li Xue Bao; 2013 Apr; 65(2):171-7. PubMed ID: 23598873
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Cyp19a1 and PPAR-γ in ovarian steroidogenic pathway by Ficus religiosa: A potential cure for polycystic ovary syndrome.
Suriyakalaa U; Ramachandran R; Doulathunnisa JA; Aseervatham SB; Sankarganesh D; Kamalakkannan S; Kadalmani B; Angayarkanni J; Akbarsha MA; Achiraman S
J Ethnopharmacol; 2021 Mar; 267():113540. PubMed ID: 33152430
[TBL] [Abstract][Full Text] [Related]
6. Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat.
Hu T; Yuan X; Ye R; Zhou H; Lin J; Zhang C; Zhang H; Wei G; Dong M; Huang Y; Lim W; Liu Q; Lee HJ; Jin W
J Nutr Biochem; 2017 Sep; 47():21-28. PubMed ID: 28501702
[TBL] [Abstract][Full Text] [Related]
7. The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome.
Piotrowska A; Pilch W; Czerwińska-Ledwig O; Zuziak R; Siwek A; Wolak M; Nowak G
Biol Trace Elem Res; 2019 Dec; 192(2):91-97. PubMed ID: 30715682
[TBL] [Abstract][Full Text] [Related]
8. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.
Nelson VL; Legro RS; Strauss JF; McAllister JM
Mol Endocrinol; 1999 Jun; 13(6):946-57. PubMed ID: 10379893
[TBL] [Abstract][Full Text] [Related]
9. Acupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor-induced rat model of polycystic ovary syndrome.
Maliqueo M; Benrick A; Marcondes RR; Johansson J; Sun M; Stener-Victorin E
Exp Physiol; 2017 Jan; 102(1):113-127. PubMed ID: 27790765
[TBL] [Abstract][Full Text] [Related]
10. Placental steroidogenesis in pregnant women with polycystic ovary syndrome.
Maliqueo M; Lara HE; Sánchez F; Echiburú B; Crisosto N; Sir-Petermann T
Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):151-5. PubMed ID: 23122578
[TBL] [Abstract][Full Text] [Related]
11. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
12. Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis.
Tang XL; Sun Z; Gong L
J Obstet Gynaecol Res; 2018 Jan; 44(1):134-143. PubMed ID: 28929602
[TBL] [Abstract][Full Text] [Related]
13. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome.
Leon L; Bacallao K; Gabler F; Romero C; Valladares L; Vega M
Steroids; 2008 Jan; 73(1):88-95. PubMed ID: 17953976
[TBL] [Abstract][Full Text] [Related]
14. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.
Medeiros SF; Barbosa JS; Yamamoto MM
J Obstet Gynaecol Res; 2015 Feb; 41(2):254-63. PubMed ID: 25256274
[TBL] [Abstract][Full Text] [Related]
15. Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.
Misugi T; Ozaki K; El Beltagy K; Tokuyama O; Honda K; Ishiko O
Gynecol Obstet Invest; 2006; 61(4):208-15. PubMed ID: 16479139
[TBL] [Abstract][Full Text] [Related]
16. Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats.
Aizawa K; Iemitsu M; Maeda S; Jesmin S; Otsuki T; Mowa CN; Miyauchi T; Mesaki N
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E577-84. PubMed ID: 17018772
[TBL] [Abstract][Full Text] [Related]
17. Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model.
Prabhu YD; Borthakur A; A G S; Vellingiri B; Valsala Gopalakrishnan A
J Reprod Immunol; 2021 Aug; 146():103345. PubMed ID: 34116484
[TBL] [Abstract][Full Text] [Related]
18. Systemic adiponectin treatment reverses polycystic ovary syndrome-like features in an animal model.
Singh A; Bora P; Krishna A
Reprod Fertil Dev; 2018 Mar; 30(4):571-584. PubMed ID: 28911368
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
